Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Determinants of Hospital Inpatient Costs in the Iranian Elderly: A Micro-costing Analysis

  • Hazrati, Ebrahim (Department of Anesthesiology and Critical Care, AJA University of Medical Sciences) ;
  • Meshkani, Zahra (Health Management and Economics Research Center, Iran University of Medical Sciences) ;
  • Barghazan, Saeed Husseini (Health Management and Economics Research Center, Iran University of Medical Sciences) ;
  • Jame, Sanaz Zargar Balaye (Department of Health Management and Economics, School of Medicine, AJA University of Medical Sciences) ;
  • Markazi-Moghaddam, Nader (Department of Health Management and Economics, School of Medicine, AJA University of Medical Sciences)
  • Received : 2019.09.04
  • Accepted : 2020.04.04
  • Published : 2020.05.29
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Aging is assumed to be accompanied by greater health care expenditures. The objective of this retrospective, bottom-up micro-costing study was to identify and analyze the variables related to increased health care costs for the elderly from the provider's perspective. Methods: The analysis included all elderly inpatients who were admitted in 2017 to a hospital in Tehran, Iran. In total, 1288 patients were included. The Mann-Whitney and Kruskal-Wallis tests were used. Results: Slightly more than half (51.1%) of patients were males, and 81.9% had a partial recovery. The 60-64 age group had the highest costs. Cancer and joint/orthopedic diseases accounted for the highest proportion of costs, while joint/orthopedic diseases had the highest total costs. The surgery ward had the highest overall cost among the hospital departments, while the intensive care unit had the highest mean cost. No statistically significant relationships were found between inpatient costs and sex or age group, while significant associations (p<0.05) were observed between inpatient costs and the type of ward, length of stay, type of disease, and final status. Regarding final status, costs for patients who died were 3.9 times higher than costs for patients who experienced a partial recovery. Conclusions: Sex and age group did not affect hospital costs. Instead, the most important factors associated with costs were type of disease (especially chronic diseases, such as joint and orthopedic conditions), length of stay, final status, and type of ward. Surgical services and medicine were the most important cost items.

Keywords

References

  1. Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 2011; 68(4):387-420. https://doi.org/10.1177/1077558711399580
  2. Ellen ME, Panisset U, de Carvalho IA, Goodwin J, Beard J. A knowledge translation framework on ageing and health. Health Policy 2017;121(3):282-291. https://doi.org/10.1016/j.healthpol.2016.12.009
  3. Ziloochi MH, Pourreza A, Akbari F, Rahimi-Foroshani A. Evaluating the hospitalization costs for elderly patients in teaching hospitals of Kashan university of medical sciences during 2009-10. J Kashan Univ Med Sci 2010;16(1):86-94 (Persian).
  4. Jacobzone S. Coping with aging: international challenges. What are the implications of greater longevity and declining disability levels? Health Aff 2000;19(3):213-225. https://doi.org/10.1377/hlthaff.19.3.213
  5. Tsuji M, Miyahara S, Taoka F, Teshima M. An estimation of economic effects of tele-home-care: hospital cost-savings of the elderly. Stud Health Technol Inform 2001;84(Pt 1):858-862.
  6. Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O'Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015;385(9967): 549-562. https://doi.org/10.1016/S0140-6736(14)61347-7
  7. Rolston KV. Polymicrobial pulmonary infections in cancer patients with underlying solid tumors. Infection 2017;45(2):245-246. https://doi.org/10.1007/s15010-016-0950-7
  8. Anderson GF, Hussey PS. Population aging: a comparison among industrialized countries. Health Aff (Millwood) 2000;19(3):191-203. https://doi.org/10.1377/hlthaff.19.3.191
  9. Chan A, Chiang YY, Low XH, Yap KY, Ng R. Affordability of cancer treatment for aging cancer patients in Singapore: an analysis of health, lifestyle, and financial burden. Support Care Cancer 2013;21(12):3509-3517. https://doi.org/10.1007/s00520-013-1930-4
  10. Tolsgaard MG, Tabor A, Madsen ME, Wulff CB, Dyre L, Ringsted C, et al. Linking quality of care and training costs: cost-effectiveness in health professions education. Med Educ 2015;49(12): 1263-1271. https://doi.org/10.1111/medu.12882
  11. Mendelson DN, Schwartz WB. The effects of aging and population growth on health care costs. Health Aff (Millwood) 1993; 12(1):119-125. https://doi.org/10.1377/hlthaff.12.1.119
  12. Reinhardt UE. Does the aging of the population really drive the demand for health care? Health Aff (Millwood) 2003;22(6): 27-39. https://doi.org/10.1377/hlthaff.22.6.27
  13. Brockmann H. Why is less money spent on health care for the elderly than for the rest of the population? Health care rationing in German hospitals. Soc Sci Med 2002;55(4):593-608. https://doi.org/10.1016/S0277-9536(01)00190-3
  14. Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur J Health Econ 2018;19(6):831-842. https://doi.org/10.1007/s10198-017-0926-2
  15. Frick KD. Micro-costing quantity data collection methods. Med Care 2009;47(7 Suppl 1):S76-S81. https://doi.org/10.1097/MLR.0b013e31819bc064
  16. Polder JJ, Barendregt JJ, van Oers H. Health care costs in the last year of life-the Dutch experience. Soc Sci Med 2006;63(7): 1720-1731. https://doi.org/10.1016/j.socscimed.2006.04.018
  17. Mcgrail K, Green B, Barer ML, Evans RG, Hertzman C, Normand C. Age, costs of acute and long-term care and proximity to death: evidence for 1987-88 and 1994-95 in British Columbia. Age Ageing 2000;29(3):249-253. https://doi.org/10.1093/ageing/29.3.249
  18. Kildemoes HW, Christiansen T, Gyrd-Hansen D, Kristiansen IS, Andersen M. The impact of population ageing on future Danish drug expenditure. Health Policy 2006;75(3):298-311. https://doi.org/10.1016/j.healthpol.2005.03.013
  19. Aplin B, Nazzal M, Qu W, Zelenock G, Kazan V, Abbas J. Patient variables impacting hospital costs from 2008 to 2010. Am J Surg 2015;210(1):134-140. https://doi.org/10.1016/j.amjsurg.2014.08.018
  20. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, et al. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 2008; 168(16):1783-1790. https://doi.org/10.1001/archinte.168.16.1783